<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Telatin V</submitter><pubmed_abstract>Chronic HCV infection is characterized by several immunological alterations, such as the accumulation of suppressor cells and of hyperactivated T lymphocytes. However, it is unclear whether direct-acting antiviral (DAA)-mediated HCV clearance restores immune dysfunctions. We performed a phenotypic characterization by flow cytometry of different immune cell subsets, including monocytic myeloid-derived suppressor cells (M-MDSCs) and T lymphocytes in 168 patients with persistent HCV infection not treated, under DAA therapies and sustained virological responders. Chronic HCV infection prompted the accumulation of M-MDSCs independently of patient and clinical characteristics, and altered their metabolic properties. HCV RNA was undetectable in the majority of patients just after few weeks of DAA</pubmed_abstract><journal>Frontiers in cellular and infection microbiology</journal><pagination>190</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6588015</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.</pubmed_title><pmcid>PMC6588015</pmcid><pubmed_authors>Menegotto N</pubmed_authors><pubmed_authors>Barbaro F</pubmed_authors><pubmed_authors>Erne E</pubmed_authors><pubmed_authors>Nicoli F</pubmed_authors><pubmed_authors>Castelli E</pubmed_authors><pubmed_authors>Frasson C</pubmed_authors><pubmed_authors>Palu G</pubmed_authors><pubmed_authors>Caputo A</pubmed_authors><pubmed_authors>Telatin V</pubmed_authors></additional><is_claimable>false</is_claimable><name>In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.</name><description>Chronic HCV infection is characterized by several immunological alterations, such as the accumulation of suppressor cells and of hyperactivated T lymphocytes. However, it is unclear whether direct-acting antiviral (DAA)-mediated HCV clearance restores immune dysfunctions. We performed a phenotypic characterization by flow cytometry of different immune cell subsets, including monocytic myeloid-derived suppressor cells (M-MDSCs) and T lymphocytes in 168 patients with persistent HCV infection not treated, under DAA therapies and sustained virological responders. Chronic HCV infection prompted the accumulation of M-MDSCs independently of patient and clinical characteristics, and altered their metabolic properties. HCV RNA was undetectable in the majority of patients just after few weeks of DAA</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-22T00:07:35.811Z</modification><creation>2019-07-24T07:25:43Z</creation></dates><accession>S-EPMC6588015</accession><cross_references><pubmed>31259160</pubmed><doi>10.3389/fcimb.2019.00190</doi></cross_references></HashMap>